EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Human neutrophil elastase inhibitors: Classification, biological‐synthetic sources and their relevance in related diseases

Jhonnatan Styver Ocampo-Gallego, David Pedroza-Escobar iD, Ana Ruth Caicedo-Ortega, María Teresa Berumen-Murra, Ana Lucía Novelo-Aguirre, Rebeca Denis de Sotelo-León, Dealmy Delgadillo-Guzmán iD

Fundamental & Clinical Pharmacology · 2024-02 · 38 (1) · 13-32

DOI: 10.1111/fcp.12946 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 23.08.2023. Verfasst von Jhonnatan Styver Ocampo-Gallego und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacologia, Facultad de Medicina UT, Universidad Autonoma de Coahuila, Torreon, Mexico. Hauptthemen laut MEDLINE: Leukocyte Elastase, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 132 Literaturangaben. Gefördert von: Facultad de Medicina, UT, Universidad Autonoma de Coahuila.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human neutrophil elastase is a multifunctional protease enzyme whose function is to break the bonds of proteins and degrade them to polypeptides or amino acids. In addition, it plays an essential role in the immune mechanism against bacterial infections and represents a key mediator in tissue remodeling and inflammation. However, when the extracellular release of this enzyme is dysregulated in response to low levels of its physiological inhibitors, it ultimately leads to the degradation of proteins, in particular elastin, as well as other components of the extracellular matrix, producing injury to epithelial cells, which can promote sustained inflammation and affect the innate immune system, and, therefore, be the basis for the development of severe inflammatory diseases, especially those associated with the cardiopulmonary system.

Objective

This review aims to provide an update on the elastase inhibitory properties of several molecules, either synthetic or biological sources, as well as their classification and relevance in related pathologies since a clear understanding of the function of these molecules with the inhibitory capacity of this protease can provide valuable information for the development of pharmacological therapies that manage to modify the prognosis and survival of various inflammatory diseases.

Methods

Collected data from scientific databases, including PubMed, Google Scholar, Science Direct, Nature, Wiley, Scopus, and Scielo. Articles published in any country and language were included.

Results

We reviewed and included 132 articles conceptualizing neutrophil elastase activity and known inhibitors.

Conclusion

Understanding the mechanism of action of elastase inhibitors based on particular aspects such as their kinetic behavior, structure–function relationship, chemical properties, origin, pharmacodynamics, and experimental progress has allowed for a broad classification of HNE inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocyte ElastaseInflammationHumansProteinase Inhibitory Proteins, SecretoryNeutrophils

Stichwörter der Autor:innen

anti-elastasehuman neutrophil elastaseinflammationpharmacologic responsephytochemical

Substanzen

Leukocyte ElastaseProteinase Inhibitory Proteins, Secretory

Autor:innen und Institutionen

  • Departamento de Farmacologia, Facultad de Medicina UT, Universidad Autonoma de Coahuila, Torreon, Mexico.
  • Departamento de Bioquimica, Centro de Investigacion Biomedica, Universidad Autonoma de Coahuila, Torreon, Mexico.
  • Departamento de Quimica, Facultad de Ciencias, Universidad Nacional de Colombia, Bogota, Colombia.
  • Departmento de Nutricion. Unidad de Medicina Familiar, UMAA 53, Instituto Mexicano del Seguro Social, Durango, Mexico.

ORCID-Profile: David Pedroza-Escobar, Dealmy Delgadillo-Guzmán

Förderung

  • Facultad de Medicina, UT, Universidad Autonoma de Coahuila

Zitieren

APA

Ocampo-Gallego, J. S., Pedroza-Escobar, D., Caicedo-Ortega, A. R., Berumen-Murra, M. T., Novelo-Aguirre, A. L., de Sotelo-León, R. D., & Delgadillo-Guzmán, D. (2024). Human neutrophil elastase inhibitors: Classification, biological‐synthetic sources and their relevance in related diseases. Fundamental & Clinical Pharmacology, 38(1), 13-32. https://doi.org/10.1111/fcp.12946

Vancouver

Ocampo-Gallego JS, Pedroza-Escobar D, Caicedo-Ortega AR, Berumen-Murra MT, Novelo-Aguirre AL, de Sotelo-León RD, et al. Human neutrophil elastase inhibitors: Classification, biological‐synthetic sources and their relevance in related diseases. Fundamental & Clinical Pharmacology. 2024;38(1):13-32. doi:10.1111/fcp.12946

BibTeX
@article{OcampoGallego2024,
  author = {Ocampo-Gallego, Jhonnatan Styver and Pedroza-Escobar, David and Caicedo-Ortega, Ana Ruth and Berumen-Murra, María Teresa and Novelo-Aguirre, Ana Lucía and de Sotelo-León, Rebeca Denis and Delgadillo-Guzmán, Dealmy},
  title = {Human neutrophil elastase inhibitors: Classification, biological‐synthetic sources and their relevance in related diseases},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2024},
  volume = {38},
  number = {1},
  pages = {13--32},
  doi = {10.1111/fcp.12946}
}
Kostenlos starten →